Advertisement

A Comparative Study Evaluating the Incidence of Colorectal Neoplasia(s) in Candidates for Bariatric Surgery by Screening Colonoscopy, 40–49 Versus 50–65 Years Old: a Preliminary Study

  • Toygar Toydemir
  • Görkem Özgen
  • İsmail Çalıkoğlu
  • Özdal Ersoy
  • Mehmet Ali YerdelEmail author
Original Contribution
  • 24 Downloads

Abstract

Introduction

Obesity and metabolic syndrome (MetS) are associated with colorectal neoplasia (CRN) and carcinoma (CRC). Whether such subjects must undergo screening colonoscopy (SC) earlier, is unknown. Incidences of CRNs in 40–49- versus 50–65-year-old bariatric patients were compared by SC. No prospective data on SC is available in morbidly obese/MetS.

Material and Methods

Surgical weight loss candidates over 39 years of age, asymptomatic, and average-risk for CRC offered SC. Those giving written informed consent were enrolled. Colonoscopies were done by the same surgeon. Smoking/drinking history, fasting blood glucose (FBG), insulin, C-peptide, triglyceride, high density lipoprotein, vitamin D, HbA1c, and insulin resistance parameters were recorded. CRN rate and the distribution of variables in patients 40–49 years of age were compared with 50–65. Student’s t and Chi-square tests were used as appropriate. P < 0.05 was regarded as statistically significant.

Results

Among 168 SCs, 47 had CRNs (27.9%). Including carcinoma, 15 had an advanced CRN (aCRN) (8.9% aCRN and 0.6% CRC). CRN rate was 35.6% in ≥ 50 years old whereas 22.1% in 40–49 (p = 0.053). aCRN rates (8.4% in 40–49 versus 9.6% in 50–65) were similar (p = 0.792). Metabolic parameters and smoking-drinking history were equally distributed between the groups except FBG and HbA1c as their mean levels were slightly higher in the 50–65 age group (p < 0.05).

Conclusions

Presented results warrant routine SC in the 40–49-year-old morbidly obese and/or MetS patient population with average risk, and in aged > 50, it certainly must be enforced and included in the preoperative check-list if not done before.

Keywords

Screening colonoscopy Obese Metabolic syndrome Morbid obesity 

Notes

Compliance with Ethical Standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Conflict of Interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569–78.CrossRefPubMedGoogle Scholar
  2. 2.
    Ben Q, An W, Jiang Y, et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology. 2012;142:762–72.CrossRefPubMedGoogle Scholar
  3. 3.
    Omata F, Deshpande GA, Ohde S, et al. The association between obesity and colorectal adenoma: systematic review and meta-analysis. Scand J Gastroenterol. 2013;48:136–46.CrossRefPubMedGoogle Scholar
  4. 4.
    Kim NH, Park JH, Park DI, et al. Metabolic syndrome is a risk factor for adenoma occurrence at surveillance colonoscopy. A single-center experience in Korea. Medicine. 2016;95:e4454.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Hu NC, Chen JD, Lin YM, et al. Stepwise relationship between components of metabolic syndrome and risk of colorectal adenoma in a Taiwanese population receiving screening colonoscopy. J Formos Med Assoc. 2011;110:100–8.CrossRefPubMedGoogle Scholar
  6. 6.
    Vu HT, Ufere N, Yan Y, et al. Diabetes mellitus increases risk for colorectal adenomas in younger patients. World J Gastroenterol. 2014;20:6946–52.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Yoon YS, Keum N, Zhang X, et al. Hyperinsulinemia, insulin resistance and colorectal adenomas: a meta-analysis. Metabolism. 2015;64:1324–33.CrossRefPubMedGoogle Scholar
  8. 8.
    Colangelo LA, Gapstur SM, Gann PH, et al. Colorectal cancer mortality and factors related to the insulin resistance syndrome. Cancer Epidemiol Biomark Prev. 2002;11:385–91.Google Scholar
  9. 9.
    Ahmed RL, Schmitz KH, Anderson KE, et al. The metabolic syndrome and risk of incident colorectal cancer. Cancer. 2006;107:28–36.CrossRefPubMedGoogle Scholar
  10. 10.
    Stürmer T, Buring JE, Lee IM, et al. Metabolic abnormalities and risk for colorectal cancer in the physicians’ health study. Cancer Epidemiol Biomark Prev. 2006;15:2391–7.CrossRefGoogle Scholar
  11. 11.
    Bowers K, Albanes D, Limburg P, et al. A prospective study of anthropometric and clinical measurements associated with insulin resistance syndrome and colorectal cancer in male smokers. Am J Epidemiol. 2006;164:652–64.CrossRefPubMedGoogle Scholar
  12. 12.
    Trevisan M, Liu J, Muti P, et al. Markers of insulin resistance and colorectal cancer mortality. Cancer Epidemiol Biomark Prev. 2001;10:937–41.Google Scholar
  13. 13.
    Stocks T, Lukanova A, Johansson M, et al. Components of metabolic syndrome and colorectal cancer risk; a prospective study. Int J Obesity. 2008;32:304–14.CrossRefGoogle Scholar
  14. 14.
    Sung JJ, Ng SC, Chan FK, et al. An updated Asia Pacific consensus recommendations on colorectal cancer screening. Gut. 2015;64:121–32.Google Scholar
  15. 15.
    Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;112:1016–30.CrossRefPubMedGoogle Scholar
  16. 16.
    Lee BI, Hong SP, Kim SE, et al. Korean guidelines for colorectal cancer screening and polyp detection. Clin Endosc. 2012;45:25–43.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon. Gastrointest Endosc. 2003;58(Suppl 6):S3–43.Google Scholar
  18. 18.
    Lin OS, Kozarek RA, Cha JM. Impact of sigmoidoscopy and colonoscopy on colorectal cancer incidence and mortality: an evidence-based review of published prospective and retrospective studies. Intest Res. 2014;12:268–74.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.CrossRefPubMedGoogle Scholar
  20. 20.
    Botteri E, Iodice S, Bagnardi V, et al. Smoking and colorectal cancer: a meta-analysis. JAMA. 2008;300:2765–78.CrossRefPubMedGoogle Scholar
  21. 21.
    Regula J, Rupinski M, Kraszewska E, et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 2006;355:1863–72.CrossRefPubMedGoogle Scholar
  22. 22.
    Hong SN, Kim JH, Choe WH, et al. Prevalence and risk of colorectal neoplasms in asymptomatic, average-risk screenees 40 to 49 years of age. Gastrointest Endosc. 2010;72:480–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Imperiale TF, Wagner DR, Lin CY, et al. Results of screening colonoscopy among persons 40 to 49 years of age. N Engl J Med. 2002;346:1781–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Strul H, Kariv R, Leshno M, et al. The prevalence rate and anatomic location of colorectal adenoma and cancer detected by colonoscopy in average-risk individuals aged 40-80 years. Am J Gastroenterol. 2006;101:255–62.CrossRefPubMedGoogle Scholar
  25. 25.
    Eisele R, Vogelsang E, Kraft K, et al. Screening for colorectal lesions with high-resolution video colonoscopes in a German male average-risk population at 40 to 59 years of age. Z Gastroenterol. 2007;45:952–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Rundle AG, Lebwohl B, Vogel R, et al. Colonoscopic screening in average risk individuals ages 40 to 49 versus 50 to 59 years. Gastroenterology. 2008;134:1311–5.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Boursi B, Halak A, Umansky M, et al. Colonoscopic screening of an average-risk population for colorectal neoplasia. Endoscopy. 2009;41:516–21.CrossRefPubMedGoogle Scholar
  28. 28.
    Choi YS, Suh JP, Lee DS, et al. Colonoscopy screening for individuals aged 40-49 years with a family history of stomach cancer in Korea. Int J Color Dis. 2010;25:443–7.CrossRefGoogle Scholar
  29. 29.
    Chung SJ, Kim YS, Yang SY, et al. Prevalence and risk of colorectal adenoma in asymptomatic Koreans aged 40-49 years undergoing screening colonoscopy. J Gastroenterol Hepatol. 2010;25:519–25.CrossRefPubMedGoogle Scholar
  30. 30.
    Thoma MN, Castro F, Golawala M, et al. Detection of colorectal neoplasia by colonoscopy in average-risk patients age 40-49 versus 50-59 years. Dig Dis Sci. 2011;56:1503–8.CrossRefPubMedGoogle Scholar
  31. 31.
    Ko HJ, Youn CH. Determination of the beginning age for colonoscopic screening among colonoscopy-naïve individuals. Clin Res Hepatol Gastroenterol. 2012;36:384–90.CrossRefPubMedGoogle Scholar
  32. 32.
    Hemmasi G, Sohrabi M, Zamani F, et al. Prevalence of colorectal adenoma in an average-risk population aged 40-50 versus 50-60 years. Eur J Cancer Prev. 2015;24:386–90.CrossRefPubMedGoogle Scholar
  33. 33.
    Jung YS, Ryu S, Chang Y, et al. Risk factors for colorectal neoplasia in persons aged 30 to 39 years and 40 to 49 years. Gastrointest Endosc. 2015;81:637–45.CrossRefPubMedGoogle Scholar
  34. 34.
    Leshno A, Moshkowitz M, David M, et al. Prevalence of colorectal neoplasms in young, average risk individuals: a turning tide between east and west. World J Gastroenterol. 2016;22:7365–72.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Park YM, Kim HS, Park JJ, et al. A simple scoring model for advanced colorectal neoplasm in asymptomatic subjects aged 40-49 years. BMC Gastroenterol. 2017;17:7.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Wong JCT, Lau JYW, Suen BY, et al. Prevalence, distribution, risk factor for colonic neoplasia in 1133 subjects aged 40-49 undergoing screening colonoscopy. J Gastroenterol Hepatol. 2017;32:92–7.CrossRefPubMedGoogle Scholar
  37. 37.
    Rosen AB, Schneider EC. Colorectal cancer screening disparities related to obesity and gender. J Gen Intern Med. 2004;19:332–8.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Maruthur NM, Bolen S, Gudzune K, et al. Body mass index and colon cancer screening: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2012;21:737–46.CrossRefGoogle Scholar
  39. 39.
    Messina CR, Lane DS, Anderson JC. Body mass index and screening for colorectal cancer: gender and attitudinal factors. Cancer Epidemiol. 2012;36:400–8.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.İstanbul Bariatrics, Obesity and Advanced Laparoscopy CenterİstanbulTurkey
  2. 2.Department of Gastroenterology, Acıbadem Fulya HospitalAcıbadem Mehmet Ali Aydınlar UniversityİstanbulTurkey

Personalised recommendations